Market Herald logo

Subscribe

Be the first with the news that moves the market
  • VIP Gloves (VIP) shares were up over 200 per cent this morning after the company has been considered an essential service by the Malaysian Government
  • VIP Gloves says its order book is fully committed until December 2020
  • These orders represent the production of approximately 100, 40-foot shipping containers of nitrile gloves, with each container holding up to four million gloves
  • Malaysia is the world’s largest manufacturer of disposable gloves, with more than 60 per cent of global production
  • The company’s Malaysian plant is operating 24 hour days
  • VIP Gloves is currently up 123 per cent on the market today, selling shares for 7.8¢ each

VIP Gloves (VIP) shares were up over 200 per cent this morning after the company has been considered an essential service by the Malaysian Government.

Glove production is in full swing at the manufacturing plant as it is operating 24 hours a day, seven days a week.

VIP Gloves says its order book is fully committed until December 2020. These orders represent the production of approximately 100, 40-foot shipping containers of nitrile gloves, with each container holding up to four million gloves.

Malaysia is the world’s largest manufacturer of disposable gloves, with more than 60 per cent of global production.

Two new production lines

The company’s two new production lines have been affected by the supplier re-alignment and fine-tuning problems. Since both new lines are under warranty, operations can only start after the adjustments are completed.

However, the suppliers fall under the non-essential workers and VIP Gloves will have to wait until April 28, when the restrictions are over.

VIP Gloves is currently up 123 per cent on the market today, selling shares for 7.8¢ each at 2:35 pm AEST.

VIP by the numbers
More From The Market Herald
The Market Herald Video

" Antisense Therapeutics (ASX:ANP) shares rise on long COVID-19 study

Antisense Therapeutics (ASX:ANP) announces the initial outcomes of its collaboration to study the neurological aspects of…
The Market Herald Video

" Immuron (ASX:IMC) shifts focus to therapeutic drug candidate

Immuron (ASX:IMC) has deprioritised SARS-COV-2 research to focus on the clinical development of its therapeutic drug…
The Market Herald Video

" Bod Australia (ASX:BOD) awarded US Hemp Authority certificate for CBD extract

Bod Australia (ASX:BOD) has been awarded US Hemp Authority Certification for its exclusive CBD extract and…
The Market Herald Video

" Fisher & Paykel (ASX:FPH) flags softer profits for first half of FY23

Fisher & Paykel Healthcare (ASX:FPH) has forecast weaker revenue and profits for the half-year to the…